HomeCompareFRERF vs MRK

FRERF vs MRK: Dividend Comparison 2026

FRERF yields 1858.74% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRERF wins by $5033115213.33M in total portfolio value
10 years
FRERF
FRERF
● Live price
1858.74%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5033115213.39M
Annual income
$4,551,425,380,688,394.00
Full FRERF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FRERF vs MRK

📍 FRERF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRERFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRERF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRERF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRERF
Annual income on $10K today (after 15% tax)
$157,992.57/yr
After 10yr DRIP, annual income (after tax)
$3,868,711,573,585,135.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FRERF beats the other by $3,868,711,573,576,806.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRERF + MRK for your $10,000?

FRERF: 50%MRK: 50%
100% MRK50/50100% FRERF
Portfolio after 10yr
$2516557606.72M
Annual income
$2,275,712,690,349,096.00/yr
Blended yield
90.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FRERF
No analyst data
Altman Z
-15.0
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRERF buys
0
MRK buys
0
No recent congressional trades found for FRERF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRERFMRK
Forward yield1858.74%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5033115213.39M$56.8K
Annual income after 10y$4,551,425,380,688,394.00$9,798.13
Total dividends collected$4998725653.45M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FRERF vs MRK ($10,000, DRIP)

YearFRERF PortfolioFRERF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$196,574$185,873.61$11,206$366.19+$185.4KFRERF
2$3,625,086$3,414,751.87$12,650$502.35+$3.61MFRERF
3$62,731,819$58,852,977.29$14,407$694.19+$62.72MFRERF
4$1,018,941,830$951,818,784.14$16,585$967.82+$1018.93MFRERF
5$15,539,075,263$14,448,807,504.54$19,342$1,363.89+$15539.06MFRERF
6$222,558,890,541$205,932,080,009.27$22,913$1,947.19+$222558.87MFRERF
7$2,994,650,764,794$2,756,512,751,915.20$27,662$2,823.89+$2994650.74MFRERF
8$37,868,179,493,233$34,663,903,174,903.54$34,159$4,173.35+$37868179.46MFRERF
9$450,177,413,737,399$409,658,461,679,639.50$43,337$6,308.80+$450177413.69MFRERF
10$5,033,115,213,387,410$4,551,425,380,688,394.00$56,776$9,798.13+$5033115213.33MFRERF

FRERF vs MRK: Complete Analysis 2026

FRERFStock

Fremont Gold Ltd., an exploration stage company, engages in the acquisition and exploration of mineral properties in the United States. The company primarily explores for gold deposit. Its properties include North Carlin project located in northern end of the Carlin trend; Cobb Creek gold project situated in Elko County, Nevada; Griffon gold project located in southwest of Ely; and Hurricane project which consists of six unpatented claims situated in Lander County. The company was formerly known as Palisades Ventures Inc. and changed its name to Fremont Gold Ltd. in June 2017. Fremont Gold Ltd. was incorporated in 2007 and is headquartered in Vancouver, Canada.

Full FRERF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FRERF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRERF vs SCHDFRERF vs JEPIFRERF vs OFRERF vs KOFRERF vs MAINFRERF vs JNJFRERF vs ABBVFRERF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.